SCHEMBL20549112

SCHEMBL20549112

COc1cnc([C@@H](C)[C@@H](C)S(N)(=O)=O)nc1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APLNR P35414 19/20 0.67
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18247273 1.00 APLNR (0.67) APLNRLMNA
SCHEMBL19551039 1.00 APLNR (0.67) APLNRLMNA
SCHEMBL19551112 0.83 APLNR (0.52) APLNR
SCHEMBL18247105 0.83 APLNR (0.52) APLNR
SCHEMBL19550736 0.81 APLNR (0.50) APLNR
SCHEMBL19551055 0.81 APLNR (0.50) APLNR
SCHEMBL22889707 0.80 APLNR (1.00) APLNR
SCHEMBL18245579 0.80 APLNR (1.00) APLNR
SCHEMBL18246348 0.80 APLNR (1.00) APLNR
SCHEMBL18246242 0.80 APLNR (1.00) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180319773-A1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180319773-A1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR TBXA2R, AGTR1, AGTR2 APLNR 4/4885LMNA 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.